2023 GOLD International COPD Conference
octubre 30, 2023
Join the international educational symposium on Chronic Obstructive Pulmonary Disease (COPD). 2023 marks the 8th Annual GOLD International COPD Conference.
Join the international educational symposium on Chronic Obstructive Pulmonary Disease (COPD). 2023 marks the 8th Annual GOLD International COPD Conference.
Register now for the Caribbean Regional COPD Symposium – Commemorating World COPD Day 2023 «Breathing is Life – Shifting Perspectives on COPD». Next Sunday, October 29, 2023, from 11:30 a.m. (ECT) / 10:30 a.m. (JA).
Our understanding of the pathogenesis of COPD has changed very significantly over the past few years.
Entrevista al Dr. Alvar Agustí en Castilla-La Mancha Despierta para hablar de la importancia diagnóstico temprano de la EPOC.
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.
The results of this post hoc analysis support the hypothesis that benralizumab reduces the risk for recurrent COPD exacerbations within the vulnerable 30-to-90–day period in the previously identified responder population.
The use of biologic therapies, including monoclonal antibodies, has revolutionized the treatment of many human diseases.
En la XXXV edición de las Jornadas Técnicas del Institut Guttmann expertos en neurorrehabilitación, en metodología XPA, en humanización y en gestión aportaron conocimientos, ideas y buenas prácticas para humanizar la gestión y la atención sanitaria en las organizaciones asistenciales.
In this expert interview, MeiLan K Han and Alvar Agustí discuss the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 executive report, which proposes a new definition for COPD and covers the latest updates in its diagnosis, management, and prevention.
Taking place on 5 July, this ERS Vision Live panel discussion will focus on new concepts in chronic obstructive pulmonary disease (COPD).